Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Giacomo Gorini

Postdoctoral Antibody Immunologist

Research

Before the COVID-19 pandemic, my research focussed on the isolation of human monoclonal antibodies (mAbs) against RH5, a protein expressed by the malaria-causing parasite Plasmodium falciparum which mediates recognition of target red blood cells.

Since the Jenner Institute started its vaccine clinical trial against COVID-19, I have contributed to the study of the vaccine-induced immune response against SARS-CoV-2 through the isolation and characterisation of monoclonal antibodies targeting the viral surface Spike glycoprotein from selected volunteers.

We have set up a high-throughput protocol that allows the isolation of tens of human mAbs against desired antigens, from blood sample to purified product, in a matter of weeks. We are currently working to optimise this protocol for isolation of murine antibodies too.

We are expanding our collaboration network to clone antibodies against a variety of antigens for treatment, research and diagnostic purposes. Collaborations are welcome.

LinkedIn